Navigation Links
Lilly and Incyte Announce Collaboration for Development and Commercialization of Oral Anti-Inflammatory and Autoimmune Therapies
Date:12/21/2009

INDIANAPOLIS and WILMINGTON, Del., Dec. 21 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (Nasdaq: INCY) announced today that they have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of Incyte's oral JAK1/JAK2 inhibitor, INCB28050, and certain follow on compounds, for inflammatory and autoimmune diseases. The lead compound, INCB28050, is currently being studied in a six-month dose-ranging Phase II trial for rheumatoid arthritis.

Under the terms of the agreement, Lilly will receive worldwide rights to develop and commercialize INCB28050 as an oral treatment for all inflammatory conditions. In exchange for these rights, Incyte will receive an initial payment of $90 million and is eligible for up to $665 million in additional potential development, regulatory, and commercialization milestones, as well as tiered, double-digit royalty payments on future global sales with rates ranging up to twenty percent if a product is successfully commercialized.

"This new alliance with Incyte reinforces Lilly's commitment to expand our presence in inflammation and autoimmunity through the development of a new class of oral anti-inflammatory therapies," said Eiry Roberts, M.D. Lilly vice president for autoimmune product development. "We look forward to continuing the development of INCB28050 in RA and initiating additional clinical studies to help address the unmet patient needs from debilitating autoimmune and inflammatory diseases."

Paul Friedman, Incyte's president and chief executive officer, stated, "Lilly's success in bringing novel therapies to market, their commitment to building a franchise in inflammation and
'/>"/>

SOURCE Eli Lilly and Company; Incyte Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... N.C. , April 24, 2015  New ... ability of consumers to educate themselves about products ... the tools and techniques available to market researchers ... the changing consumer marketplace, it,s imperative that organizations ... to better identify market opportunities, niches and growth ...
(Date:4/24/2015)... --  Vestagen Technical Textiles, Inc. today announced that ... received two notable innovation awards. The first is the ... with potential to create a positive impact in the ... New York City , VESTEX received the Silver ... category. The awards honor excellence in new product and ...
(Date:4/24/2015)... Boston Scientific Corporation (NYSE: BSX ) is scheduled to ... Conference on May 6 in Boston . ... chief financial officer, and Susie Lisa , vice president, ... session regarding the company with the host analyst at approximately ... presentation and question and answer session will be available on ...
Breaking Medicine Technology:Pharmaceutical Industry Using New Technologies to Adjust Their Marketing and Research Approaches for Consumers 2VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 2VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 3Boston Scientific To Participate In The Deutsche Bank 40th Annual Healthcare Conference 2
... discomfort as #1 reason to avoid discussing ED, a ... potential precursor to heart disease, INDIANAPOLIS, ... men with erectile dysfunction (ED) surveyed,recognize it as an indicator of ... have never discussed the condition,with their doctors. The survey, conducted by ...
... Ga., July 15 Abeome Corporation, a,Georgia-based ... by Cato BioVentures and a collaboration with ... development organization. The investment,and collaboration will help ... project., Abeome,s proprietary technology vastly improves ...
Cached Medicine Technology:The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 2The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 3The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 4The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 5Abeome and Cato Research to Collaborate on Ovarian Cancer Therapeutic 2
(Date:4/25/2015)... 25, 2015 By definition, a CIO’s responsibility ... the enterprise relying on their judgement and expertise to keep ... according to an article published in National Mortgage News ... be doing a disservice to their responsibilities by focusing too ... t’s are crossed when it comes to company policy and ...
(Date:4/25/2015)... (PRWEB) April 25, 2015 Parker and Sons ... and cooling, has spiked in Arizona alongside the growing economy. ... additional forty employees for April to help account for the ... forty employees in April is something we are enthusiastic about. ... said Paul Kelly, president at Parker and Sons. , Indeed, ...
(Date:4/25/2015)... For thirteen years, the Twin Cities DI ... event in the nation! This year, on May 5th, 2015, ... to take DI Day on the road by supporting the ... ChFC, RHU, DIA, CLTC, Chief Executive Officer at Secura Consultants ... the change by stating, "The first Twin Cities DI Day ...
(Date:4/24/2015)... 24, 2015 As the nation recognizes ... unique sacrifices of these young men and women, the ... Veterans and their Families” presents a special training session ... to gain a better understanding of the effect of ... For those – civilian and military – who provide ...
(Date:4/24/2015)... 2015 Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ... federal multidistrict litigation underway in U.S. District Court, ... the parties involved in the proceeding submitted a ... other things, preparation for the litigation’s upcoming bellwether ... plaintiffs and defendants have conducted depositions of non-party ...
Breaking Medicine News(10 mins):Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 2Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 3Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 4Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 5Health News:Parker and Sons Plans to Expand in 2015 2Health News:Secura Consultants Takes DI Day On The Road 2Health News:Coalition Presents Resiliency Training to Raise Awareness during Month of the Military Child (#MOTMC2015) 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 3
... Seed Oil for ... SEGUNDO, Calif., Feb. 25 When it comes ... antioxidant and cell,membrane benefits, not everything with pomegranate ... extract that counts! The Murad Vitalic(R) line with,Energizing ...
... Fla., Feb. 25 The Quantum Group,Inc. (Amex: ... that,Noel J. Guillama, President & CEO, will present ... on Thursday, February 28, 2008, which will,be held ... The presentations will be held in the ...
... New Haven, Conn. Erin Lavik , an ... was honored recently by the Connecticut Technology Council ... , The annual event, now in its fourth year, ... as small business owners, entrepreneurs, researchers, community leaders and ...
... Most Oscar pundits are obsessed,with red-carpet fashion, but Hollywood ... Academy Awards with a critic,s eye for,the best and ... smiles and simply,adequate smiles are really easy to notice ... Oscar party at The Oaks Center for Cosmetic,Dentistry., ...
... EZ-Access Patcom to Streamline Hospital,s Operations and Revenue ... ... Keane, Inc., a $1,billion-plus global services firm that specializes in enabling,transformation of ... a contract with Mount Sinai Hospital of Queens,part of New York-based Mount ...
... global warming by making people more aware of their ... Satellite Navigation Competition, sponsored by ESAs Technology Transfer Programme, ... , Concerned about global warming, many people are now ... dioxide (CO2). One option is to use public transport ...
Cached Medicine News:Health News:Super Charge the Skin with Murad Vitalic(R) Featuring Energizing Pomegranate Complex(TM) 2Health News:Super Charge the Skin with Murad Vitalic(R) Featuring Energizing Pomegranate Complex(TM) 3Health News:The Quantum Group to Present at the Jesup & Lamont Emerging Growth Stock Conference on February 28th 2Health News:The Quantum Group to Present at the Jesup & Lamont Emerging Growth Stock Conference on February 28th 3Health News:Yale scientist honored for academic innovation and leadership 2Health News:Keane Wins Revenue Cycle Management Implementation With Mount Sinai Hospital of Queens 2Health News:Keane Wins Revenue Cycle Management Implementation With Mount Sinai Hospital of Queens 3Health News:Tracking your carbon footprint 2Health News:Tracking your carbon footprint 3
... Artis dFC Magnetic Navigation was developed ... Magnetic catheter navigation is a unique, ... cardiology. Assisted by two cutting-edge magnets, ... catheter and guide wires through the ...
The AXIOM Artis TC is ideal for applications above and beyond standard cardioangiography, and features:, Single plane C-Arm, ceiling-mounted, Full-size CCD camera, ...
... system PLUS is ... transesophageal cardiovascular imaging system ... array echocardiography system that provides ... even on your most technically ...
MAGNETOM Symphony, an imaging system that offers 1.5T performance and top image quality in a short bore design....
Medicine Products: